sch 58261 has been researched along with psb603 in 1 studies
| Studies (sch 58261) | Trials (sch 58261) | Recent Studies (post-2010) (sch 58261) | Studies (psb603) | Trials (psb603) | Recent Studies (post-2010) (psb603) |
|---|---|---|---|---|---|
| 46 | 0 | 14 | 14 | 0 | 13 |
| Protein | Taxonomy | sch 58261 (IC50) | psb603 (IC50) |
|---|---|---|---|
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0005 | |
| Adenosine receptor A3 | Rattus norvegicus (Norway rat) | 0.0007 | |
| Adenosine receptor A2b | Homo sapiens (human) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaba, S; Gupta, GD; Monga, V; Patel, R; Saini, A; Singh, G | 1 |
1 review(s) available for sch 58261 and psb603
| Article | Year |
|---|---|
Adenosine receptor antagonists: Recent advances and therapeutic perspective.
Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship | 2022 |